Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 97

1.

Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine.

Fais S, O'Driscoll L, Borras FE, Buzas E, Camussi G, Cappello F, Carvalho J, Cordeiro da Silva A, Del Portillo H, El Andaloussi S, Ficko Trček T, Furlan R, Hendrix A, Gursel I, Kralj-Iglic V, Kaeffer B, Kosanovic M, Lekka ME, Lipps G, Logozzi M, Marcilla A, Sammar M, Llorente A, Nazarenko I, Oliveira C, Pocsfalvi G, Rajendran L, Raposo G, Rohde E, Siljander P, van Niel G, Vasconcelos MH, Yáñez-Mó M, Yliperttula ML, Zarovni N, Zavec AB, Giebel B.

ACS Nano. 2016 Apr 26;10(4):3886-99. doi: 10.1021/acsnano.5b08015. Epub 2016 Mar 15.

PMID:
26978483
2.

Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper.

Lener T, Gimona M, Aigner L, Börger V, Buzas E, Camussi G, Chaput N, Chatterjee D, Court FA, Del Portillo HA, O'Driscoll L, Fais S, Falcon-Perez JM, Felderhoff-Mueser U, Fraile L, Gho YS, Görgens A, Gupta RC, Hendrix A, Hermann DM, Hill AF, Hochberg F, Horn PA, de Kleijn D, Kordelas L, Kramer BW, Krämer-Albers EM, Laner-Plamberger S, Laitinen S, Leonardi T, Lorenowicz MJ, Lim SK, Lötvall J, Maguire CA, Marcilla A, Nazarenko I, Ochiya T, Patel T, Pedersen S, Pocsfalvi G, Pluchino S, Quesenberry P, Reischl IG, Rivera FJ, Sanzenbacher R, Schallmoser K, Slaper-Cortenbach I, Strunk D, Tonn T, Vader P, van Balkom BW, Wauben M, Andaloussi SE, Théry C, Rohde E, Giebel B.

J Extracell Vesicles. 2015 Dec 31;4:30087. doi: 10.3402/jev.v4.30087. eCollection 2015.

3.

The Role of Exosomes in Breast Cancer.

Lowry MC, Gallagher WM, O'Driscoll L.

Clin Chem. 2015 Dec;61(12):1457-65. doi: 10.1373/clinchem.2015.240028. Epub 2015 Oct 14. Review.

PMID:
26467503
4.

miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity.

O'Brien K, Lowry MC, Corcoran C, Martinez VG, Daly M, Rani S, Gallagher WM, Radomski MW, MacLeod RA, O'Driscoll L.

Oncotarget. 2015 Oct 20;6(32):32774-89. doi: 10.18632/oncotarget.5192.

5.

Advances in the synthesis of functionalised pyrrolotetrathiafulvalenes.

O'Driscoll LJ, Andersen SS, Solano MV, Bendixen D, Jensen M, Duedal T, Lycoops J, van der Pol C, Sørensen RE, Larsen KR, Myntman K, Henriksen C, Hansen SW, Jeppesen JO.

Beilstein J Org Chem. 2015 Jul 3;11:1112-22. doi: 10.3762/bjoc.11.125. eCollection 2015.

6.

Expanding on exosomes and ectosomes in cancer.

O'Driscoll L.

N Engl J Med. 2015 Jun 11;372(24):2359-62. doi: 10.1056/NEJMcibr1503100. No abstract available.

PMID:
26061842
7.

Biological properties of extracellular vesicles and their physiological functions.

Yáñez-Mó M, Siljander PR, Andreu Z, Zavec AB, Borràs FE, Buzas EI, Buzas K, Casal E, Cappello F, Carvalho J, Colás E, Cordeiro-da Silva A, Fais S, Falcon-Perez JM, Ghobrial IM, Giebel B, Gimona M, Graner M, Gursel I, Gursel M, Heegaard NH, Hendrix A, Kierulf P, Kokubun K, Kosanovic M, Kralj-Iglic V, Krämer-Albers EM, Laitinen S, Lässer C, Lener T, Ligeti E, Linē A, Lipps G, Llorente A, Lötvall J, Manček-Keber M, Marcilla A, Mittelbrunn M, Nazarenko I, Nolte-'t Hoen EN, Nyman TA, O'Driscoll L, Olivan M, Oliveira C, Pállinger É, Del Portillo HA, Reventós J, Rigau M, Rohde E, Sammar M, Sánchez-Madrid F, Santarém N, Schallmoser K, Ostenfeld MS, Stoorvogel W, Stukelj R, Van der Grein SG, Vasconcelos MH, Wauben MH, De Wever O.

J Extracell Vesicles. 2015 May 14;4:27066. doi: 10.3402/jev.v4.27066. eCollection 2015.

8.

Dairy proteins, dairy lipids, and postprandial lipemia in persons with abdominal obesity (DairyHealth): a 12-wk, randomized, parallel-controlled, double-blinded, diet intervention study.

Bohl M, Bjørnshave A, Rasmussen KV, Schioldan AG, Amer B, Larsen MK, Dalsgaard TK, Holst JJ, Herrmann A, O'Neill S, O'Driscoll L, Afman L, Jensen E, Christensen MM, Gregersen S, Hermansen K.

Am J Clin Nutr. 2015 Apr;101(4):870-8. doi: 10.3945/ajcn.114.097923. Epub 2015 Jan 14.

9.

Reversible thermal switching of aqueous dispersibility of multiwalled carbon nanotubes.

O'Driscoll LJ, Welsh DJ, Bailey SW, Visontai D, Frampton H, Bryce MR, Lambert CJ.

Chemistry. 2015 Mar 2;21(10):3891-4. doi: 10.1002/chem.201405804. Epub 2015 Jan 29.

PMID:
25639258
10.

Neuromedin U: a multifunctional neuropeptide with pleiotropic roles.

Martinez VG, O'Driscoll L.

Clin Chem. 2015 Mar;61(3):471-82. doi: 10.1373/clinchem.2014.231753. Epub 2015 Jan 20. Review.

11.

Predictive biomarkers for dasatinib treatment in melanoma.

Eustace AJ, Kennedy S, Larkin AM, Mahgoub T, Tryfonopoulos D, O'Driscoll L, Clynes M, Crown J, O'Donovan N.

Oncoscience. 2014 Mar 12;1(2):158-66. eCollection 2014.

12.

Interpersonal rejection results in increased appearance satisfaction for women who rely on body weight for self-worth.

O'Driscoll LM, Jarry JL.

Body Image. 2015 Jan;12:36-43. doi: 10.1016/j.bodyim.2014.09.003. Epub 2014 Oct 21.

PMID:
25462880
13.

Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies.

O'Neill S, O'Driscoll L.

Obes Rev. 2015 Jan;16(1):1-12. doi: 10.1111/obr.12229. Epub 2014 Nov 18. Review.

PMID:
25407540
14.

Receptor tyrosine kinases and drug resistance: development and characterization of in vitro models of resistance to RTK inhibitors.

Corcoran C, O'Driscoll L.

Methods Mol Biol. 2015;1233:169-80. doi: 10.1007/978-1-4939-1789-1_16.

PMID:
25319899
15.

Receptor tyrosine kinase targeting in multicellular spheroids.

Breslin S, O'Driscoll L.

Methods Mol Biol. 2015;1233:161-8. doi: 10.1007/978-1-4939-1789-1_15.

PMID:
25319898
16.

Analysis of changes in phosphorylation of receptor tyrosine kinases: antibody arrays.

Rani S, O'Driscoll L.

Methods Mol Biol. 2015;1233:15-23. doi: 10.1007/978-1-4939-1789-1_2.

PMID:
25319885
17.

miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.

Corcoran C, Rani S, O'Driscoll L.

Prostate. 2014 Sep;74(13):1320-34. doi: 10.1002/pros.22848. Epub 2014 Jul 22.

PMID:
25053345
18.

Neuromedin U: a candidate biomarker and therapeutic target to predict and overcome resistance to HER-tyrosine kinase inhibitors.

Rani S, Corcoran C, Shiels L, Germano S, Breslin S, Madden S, McDermott MS, Browne BC, O'Donovan N, Crown J, Gogarty M, Byrne AT, O'Driscoll L.

Cancer Res. 2014 Jul 15;74(14):3821-33. doi: 10.1158/0008-5472.CAN-13-2053. Epub 2014 May 29.

19.

miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer.

Corcoran C, Rani S, Breslin S, Gogarty M, Ghobrial IM, Crown J, O'Driscoll L.

Mol Cancer. 2014 Mar 24;13:71. doi: 10.1186/1476-4598-13-71.

20.

Exosomes are involved in mediating radiation induced bystander signaling in human keratinocyte cells.

Jella KK, Rani S, O'Driscoll L, McClean B, Byrne HJ, Lyng FM.

Radiat Res. 2014 Feb;181(2):138-45. doi: 10.1667/RR13337.1. Epub 2014 Feb 6.

PMID:
24502353
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk